|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1a- and
1b-Adrenergic Receptor Subtypes: The Potential Role of Receptor Interaction with β-Arrestins and AP50Département de Pharmacologie et Toxicologie, Faculté de Biologie et de Médecine, Lausanne, Switzerland
The internalization properties of the
1a- and
1b-adrenergic receptors (ARs) subtypes transiently expressed in human embryonic kidney (HEK) 293 cells were compared using biotinylation experiments and confocal microscopy. Whereas the
1b-AR displayed robust agonist-induced endocytosis, the
1a-AR did not. Constitutive internalization of the
1a-AR was negligible, whereas the
1b-AR displayed significant constitutive internalization and recycling. We investigated the interaction of the
1-AR subtypes with β-arrestins 1 and 2 as well as with the AP50 subunit of the clathrin adaptor complex AP2. The results from both coimmunoprecipitation experiments and β-arrestin translocation assays indicated that the agonistinduced interaction of the
1a-AR with β-arrestins was much weaker than that of the
1b-AR. In addition, the
1a-AR did not bind AP50. The
1b-AR mutant M8, lacking the main phosphorylation sites in the receptor C tail, was unable to undergo endocytosis and was profoundly impaired in binding β-arrestins despite its binding to AP50. In contrast, the
1b-AR mutant
R8, lacking AP50 binding, bound β-arrestins efficiently, and displayed delayed endocytosis. RNA interference showed that β-arrestin 2 plays a prominent role in
1b-AR endocytosis. The findings of this study demonstrate differences in internalization between the
1a- and
1b-AR and provide evidence that the lack of significant endocytosis of the
1a-AR is linked to its poor interaction with β-arrestins as well as with AP50. We also provide evidence that the integrity of the phosphorylation sites in the C tail of the
1b-AR is important for receptor/β-arrestin interaction and that this interaction is the main event triggering receptor internalization.
Address correspondence to: Prof. Susanna Cotecchia, Département de Pharmacologie et de Toxicologie, Rue du Bugnon 27, CH-1005 Lausanne. E-mail: susanna.cotecchia{at}unil.ch